At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill

Description

The main aim of this study is to determine the impact of digital health technology, such as Alexa Skill, used to support the initiation of home-based subcutaneous immunoglobulin (SCIG) treatment, treatment management, and overall participant experience.

Conditions

Primary Immunodeficiency Diseases (PID)

Talk to us

Study Overview

On this page

Study Details

Study overview

The main aim of this study is to determine the impact of digital health technology, such as Alexa Skill, used to support the initiation of home-based subcutaneous immunoglobulin (SCIG) treatment, treatment management, and overall participant experience.

Evaluating the Treatment Experience During Initiation of Subcutaneous Immunoglobulin Replacement (SCIG) Therapy at Home Using Alexa Skill

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using Alexa Skill

Condition
Primary Immunodeficiency Diseases (PID)
Intervention / Treatment

-

Contacts and Locations

Raleigh

Research Triangle Park, Raleigh, North Carolina, United States, 27709

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult patient (aged 18 years or older) with PID who recently initiated (within 4 months) or will soon initiate (within 30 days) HyQvia or Cuvitru at home or caregiver (aged 18 years or older) supporting participants (any age) with PID who recently initiated (within 4 months) or will soon initiate (within 30 days) HyQvia or Cuvitru at home.
  • * Patient has a self-reported physician diagnosis of PID.
  • * Resides in the US or US territories.
  • * Can speak and read English fluently.
  • * Able to participate in an interview(s).
  • * Must have a wireless network (Wi-Fi) at home (cannot be a wireless hotspot).
  • * Must have an existing Amazon account.
  • * Must be willing to receive an Amazon Echo Show device and connect the device to Wi-Fi.
  • * Must have a smartphone and be willing to download and use the Alexa application to access the Alexa Skill test.
  • * Must have at least 2 SCIG infusions (HyQvia or Cuvitru) at a residential home or residential assisted living facility within 6 to12 weeks.
  • * Must attest to use of Alexa Skill to support at-home SCIG infusions.
  • * Resides in the US or US territories.
  • * Must be an immunologist or registered nurse/nurse practitioner.
  • * Licensed to practice in the US.
  • * Can speak and read English fluently.
  • * Able to participate in a debriefing interview.
  • * Willing to provide informed consent.
  • * Must have a wireless network (Wi-Fi).
  • * Must have an existing Amazon account.
  • * Must be willing to receive an Amazon Echo Show device and connect the device to Wi-Fi.
  • * Must have a smartphone and be willing to download and use the Alexa application to access the Alexa Skill test.
  • * Must attest to exploration of Alexa Skill as a support tool for patients and caregivers administering SCIG infusions at home.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Takeda,

Study Director, STUDY_DIRECTOR, Takeda

Study Record Dates

2024-12-31